Where does Intima Bioscience, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Intima Bioscience, Inc. ranks #21,288 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Intima Bioscience, Inc. hold?

Intima Bioscience, Inc. holds 13 US utility patents granted between 2019 and 2024, spanning 4 technology areas.

What is Intima Bioscience, Inc.'s Innovation Score?

Intima Bioscience, Inc. has an Innovation Score of 39.0 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Intima Bioscience, Inc.'s patent grant rate increasing or decreasing?

Intima Bioscience, Inc.'s recent grant velocity is +450% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Intima Bioscience, Inc.'s patents?

Intima Bioscience, Inc.'s patents average 25.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Intima Bioscience, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Intima Bioscience, Inc.

Q: What technology areas does Intima Bioscience, Inc. focus on?

Intima Bioscience, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 13 patents, ranking #809 of 4,144 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 13 granted patents across 4 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Intima ranks #21,288 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 4 technology areas.

#21,288
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.0/100): 25.5
avg claims per patent: +450%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21288 · US Corporation #21,288 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,288/49,997
PHOTO-FINISH Institute OF Soil…
CPC-NARROW C12N · 4 areas
INNOV-THIN 39.0/100
CLAIMS-DENSE 25.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +450% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Institute OF Soil Science, Chinese Academy OF Sciences (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Intima’s 39.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (23%) Velocity 7.8 pts (20%) Breadth 7.1 pts (18%) Claim depth 15.0 pts (38%)

Qualcomm Incorporated · highest

85
Intima Bioscience · this assignee

39
3D Lighting… · lowest

7

What this shows Intima's Innovation Score is 39.0/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Intima?

Each dot is one of Intima’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Intima’s own 25.5 claims/patent is ABOVE the 6.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Intima vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Intima's grants concentrate

Intima Bioscience, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2021 (4 grants) versus a trough of 2 in 2019. By volume, Intima sits between Institute OF Soil Science, Chinese Academy OF Sciences and Iriver Limited.

Intima's three-year grant acceleration

Intima Bioscience, Inc. shows 7 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Institute OF Soil…

13
Integral Developm…

13
Intelligent Platf…

13
International N&h…

13
Intwine Connect

13
Invanti(Beijing)T…

13
Ipevo

13
Iriver

13
Intima Bioscience ◀

13

What this shows Intima holds 13 patents at rank #21,269, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Intima

By rank, the assignees closest to #21,269 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Intima's primary technology class.

Intima's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Intima Bioscience, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	2	15.4%
2021	4	30.8%
2022	2	15.4%
2023	3	23.1%
2024	2	15.4%

Which technologies does Intima Bioscience, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 13

C07K - Peptides 13

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Intima Bioscience, Inc.'s patent record in context - here's where to go next.

Intima Bioscience, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #21,288 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Intima Bioscience, Inc. against Institute OF Soil Science, Chinese Academy OF Sciences, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.